Use of whole blood for analysis of disease-associated biomarkers.
Analyses for diagnosis and monitoring of pathological conditions often rely on blood samples, partly due to relative ease of collection. However, many interfering substances largely preclude the use of whole blood itself, necessitating separation of plasma or serum. We present a feasibility study de...
Main Authors: | May, J, Pemberton, R, Hart, J, McLeod, J, Wilcock, G, Doran, O |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study.
by: Wouter van Rheenen, et al.
Published: (2018-01-01) -
Measurement of Redox Biomarkers in the Whole Blood and Red Blood Cell Lysates of Dogs
by: Luis G. González-Arostegui, et al.
Published: (2022-02-01) -
Whole blood transcriptome biomarkers of unruptured intracranial aneurysm.
by: Kerry E Poppenberg, et al.
Published: (2020-01-01) -
Splitting Things Apart to Put Them Back Together Again: A Targeted Review and Analysis of Psychological Therapy RCTs Addressing Recovery From Negative Symptoms
by: Hamish J. McLeod
Published: (2022-05-01) -
Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood
by: Samantha E. Day, et al.
Published: (2017-04-01)